| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/03/2006 | US20060171887 Method for the diagnosis of helicobacter pylori infection and diagnostic kit for performing the method |
| 08/03/2006 | US20060171886 Method for characterizing the oxidative stress protective capacity of an antioxidative substance |
| 08/03/2006 | DE102005005528A1 Using nucleic acid to prepare injectable agent for transportation to retinal ganglion cells, useful in treatment of glaucoma and diabetic complications of the eye, acts especially by RNA intereference |
| 08/03/2006 | DE102005004385A1 New perylene dye compounds useful e.g. as pigment for watercolor and colors for inkjet printer, printing ink, as fluorescence dye in data storage, preferably in optical storage such as compact disk and digital compact disk |
| 08/03/2006 | DE102005002483A1 Verfahren zum Einkapseln von Sensormolekülen mit einer semipermeablen Membran A method of encapsulating by sensor molecules with a semipermeable membrane |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 08/02/2006 | EP1684808A1 A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes |
| 08/02/2006 | EP1684807A1 Method of identifying responders to treatment with insulin sensitizers |
| 08/02/2006 | EP1684804A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 08/02/2006 | EP1684799A2 Rescue agents for treating botulinum toxin intoxications |
| 08/02/2006 | EP1684724A2 Enhanced drug delivery |
| 08/02/2006 | EP1684723A1 Contrast medium comprising liposomes containing hydrophobic chelate compound |
| 08/02/2006 | EP1684682A2 Reduction of unintended use of transdermal devices |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1036339B1 Sol-gel coated polarization vessels |
| 08/02/2006 | EP0730472B1 Immobilized labelling method |
| 08/02/2006 | CN1812776A Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 08/02/2006 | CN1810293A Magnetic resonance imaging contrast medium based on metal fullerene and its prepn process |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | US7083797 32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
| 08/01/2006 | US7083796 Fusion proteins of mycobacterium tuberculosis |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | US7083778 Ultrasound contrast agents and methods of making and using them |
| 08/01/2006 | US7083572 Therapeutic delivery systems |
| 07/27/2006 | WO2006079091A1 Methods of providing long-term stability to biocompatible optical dyes and bodily fluids |
| 07/27/2006 | WO2006076826A1 An ultrasonic contrast composition having phospholipid as film-former and the preparation method thereof |
| 07/27/2006 | WO2006053252A3 Methods of treating hematological malignancies with nucleoside analog drugs |
| 07/27/2006 | WO2006026184A3 Blood brain barrier permeation peptides |
| 07/27/2006 | WO2006017333B1 Shortened carbon nanotubes |
| 07/27/2006 | WO2005104696A3 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 07/27/2006 | WO2005092922A3 Antigen of the pm-2 antibody and use thereof |
| 07/27/2006 | WO2005070472A3 High frequency ultrasound imaging using contrast agents |
| 07/27/2006 | WO2004110339A3 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 07/27/2006 | US20060165804 Polymer compositions for administration to animals |
| 07/27/2006 | US20060165767 Thermolabile liposome with a controlled release temperature |
| 07/27/2006 | US20060165712 can catalyze site-selective acyl transfer |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165606 Perforated microstructure; efficiently depositing compound at site of action; minimizing toxic side effects, lowering dosing requirements |
| 07/27/2006 | US20060165602 Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 07/27/2006 | US20060165601 a linear polyethylene glycol modified with 2,2-bis(hydroxymethyl)propionic acid and diethylenetriaminepentacetic acid as a chelator to stabilize gadolinium, used as imaging agents having low toxicity |
| 07/27/2006 | US20060165600 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 07/27/2006 | US20060165599 Near infrared imaging agent |
| 07/27/2006 | US20060165598 Using water soluble dyes; contrast media for fluorescence |
| 07/27/2006 | US20060165597 Methods for cancer imaging |
| 07/27/2006 | US20060165596 Method and apparatus for noninvasively evaluating endothelial function |
| 07/27/2006 | US20060165595 In vivo angiogenesis assay |
| 07/27/2006 | US20060165594 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 07/27/2006 | US20060165591 Metal complex-containing pharmaceutical agents |
| 07/27/2006 | US20060163526 high pressure homogenization; high throughput screening |
| 07/27/2006 | DE4447927B4 Granular polymer composites - useful for immobilisation of antigens or antibodies |
| 07/27/2006 | CA2595612A1 Methods and compositions related to tr4 |
| 07/27/2006 | CA2595403A1 Modulation of th2 lineage commitment by t-bet |
| 07/26/2006 | EP1682660A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/26/2006 | EP1682652A2 Nanofibrillar structure and applications including cell and tissue culture |
| 07/26/2006 | EP1682188A2 Novel diagnostic agent for mri in proteinase-related diseases |
| 07/26/2006 | EP1682170A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 07/26/2006 | EP1682113A1 Inhibitor imaging agents |
| 07/26/2006 | EP1682037A1 Post-biopsy cavity treatment implants and methods |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1047454B1 Methods of screening compounds useful for prevention of infection or pathogenicity |
| 07/26/2006 | EP0985028B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 07/26/2006 | EP0929303B1 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| 07/26/2006 | CN1809750A Acetyl-coenzyme A carboxylase 2 as a target in the regulation of fat and insulin action |
| 07/26/2006 | CN1809386A Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for 'CEST' applications |
| 07/25/2006 | US7081472 Reacting a substituted bis- indole compound with a chelating agent |
| 07/25/2006 | US7081452 Diagnosis, therapy, image of celluloar disorders; antitumor agents |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | US7081238 Assessing the level of dopamine transporter in at least one region of the patient's central nervous system, by binding a dopamine transporter ligand to the dopamine transporters using tomography |
| 07/25/2006 | US7081092 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 07/25/2006 | CA2156935C Methods of detecting collagen degradation in vivo |
| 07/20/2006 | WO2006076698A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 07/20/2006 | WO2006076517A1 Attenuated mycobacteria as vectors for gene delivery to mammalian cells |
| 07/20/2006 | WO2006076343A1 Mycobacteria expressing hiv-1 and malaria antigens |
| 07/20/2006 | WO2004091382A3 Monitoring circadian activity |
| 07/20/2006 | US20060161998 Non-traumatic model for neurogenic pain |
| 07/20/2006 | US20060161062 Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging |
| 07/20/2006 | US20060160901 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 07/20/2006 | US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | US20060159623 Stem cells for use in locating and targeting tumor cells |
| 07/20/2006 | US20060159622 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 07/20/2006 | US20060159621 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 07/20/2006 | US20060159620 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 07/20/2006 | US20060159616 Methods for detecting endocrine cancer |
| 07/20/2006 | DE19507822B4 Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel Substituted DTPA-monoamides of central carboxylic acid and their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics and therapy and methods for preparing the complexes and agents |
| 07/20/2006 | DE102005000918A1 Verfahren zur Herstellung wässriger Kompositpartikel-Dispersionen A process for preparing aqueous dispersions of composite particles |
| 07/20/2006 | CA2594328A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 07/19/2006 | EP1680657A2 Dmbt1 as a clinical marker and uses thereof |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680146A2 Embolic compositions comprising particles |
| 07/19/2006 | EP1679960A1 Transgenic amphibian models for lymphatic vessel development |
| 07/19/2006 | CN1805769A CNS chloride modulation and uses thereof |
| 07/19/2006 | CN1805712A Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging |
| 07/19/2006 | CN1803765A Method for preparing ioxitalamic acid |
| 07/19/2006 | CN1803197A Grain analog assistant for high-intensity focusing ultrasonic therapy and its uses |
| 07/19/2006 | CN1803196A Fluorocarbonemulsion analog assistant for high-intensity focusing ultrasonic therapy and its uses |
| 07/19/2006 | CN1803191A Assistant for high-intensity focusing ultrasonic therapy and its screening method |